Videos featuring Deloitte Center for Health Solutions ­ List of Organizations

The COVID-19 pandemic has turned the health care industry upside down and accelerated many of the ideas for the future that some thought would take decades to take hold. This session assists attendees in addressing the question: will these changes persist, or will hospitals go back to how they’ve always done business? The speed to decision and execution in this recovery phase is critical. Hospitals cannot go back to their old business models. It most likely is not viable given where health care is heading. As the industry begins to recover from the pandemic, hospital executives should consider how they can maintain their momentum toward operating as a hospital of the future and position their organizations to thrive. 

Discussion includes:

  • Implications of how COVID-19 has accelerated future hospital transformation
  • The three emerging themes on how hospitals are transforming
  • Consideration for what parts of hospital COVID-19 responses should remain part of their new normal
  • Steps for those entering the recovery phase of the pandemic toward how to ensure their organizations will thrive

What will the health plan of tomorrow look like? How will traditional health plans transform, and what choices do leaders need to make now to survive the forthcoming disruption? To begin answering these questions, the Deloitte Center for Health Solutions conducted crowd-sourcing research with 28 health care, policy, and technology experts. Over four days, these experts presented and discussed use cases for the next innovation cycle with a focus on four key areas: customer centricity; innovation; collaboration; and operational excellence.

This session examines novel payer analytic techniques ranging from retrospective data analysis to predictive modeling, that can help health plans and PBMs leverage their data to identify people at high risk for opioid misuse. The role of emerging technologies including virtual care, digital therapeutics, remote patient monitoring, AI and more are explored.

New Deloitte Center for Health Solutions research explores five key findings from analyses of the financial performance of commercial health plans. Deloitte's study focuses on the fully insured commercial group and commercial individual books of business of US health plans. The study uses financial data reported by insurers to CMS according to statutory accounting principles.

Compared to the financial performance of US health plans overall, how have government programs fared over the past few years? New Deloitte Center for Health Solutions research explores six trends in Medicare Advantage and Medicaid managed care. This research focuses on information health plans are required to file with the National Association of Insurance Commissioners (NAIC).

Medicaid can be overlooked in conversations about value-based strategy, but state initiatives can present major opportunities or challenges for health plans and health care providers. ​Many states have been experimenting with Medicaid alternative payment models (APMs) to try to control spending, improve care, and increase accountability within Medicaid and across the health care system. But have any of these models worked? And how might Medicaid initiatives align with the Medicare Quality Payment Program (QPP) established by the Medicare Access and CHIP Reauthorization Act (MACRA) to reinforce value-based care initiatives and drive system-wide change?

Today’s health care executive is considering many strategies to drive value. How can bundled payments and post-acute care fit into an organization’s future plans? 

Results from Deloitte’s 2016 Survey of US Health Care Consumers and Deloitte's study on Realizing the potential of telehealth report on trends in telehealth and consumer interest; with a discussion of the regulatory landscape; and the potential barriers, opportunities, and enablers for telehealth in the coming years.

This presentation will review the findings and implications from the survey of executives from hospital/health systems, health plans, biopharmaceutical companies, and medical technology companies, regarding awareness, preparedness, and perceptions about MACRA.

Findings from the Deloitte Center for Health Solutions Survey of US Health Care Consumers, and sharing of perspectives, insights and potential stakeholder strategies regarding Public Health Exchanges and Consumer Engagement.